Author Review — Track Authors' Data

Concise appraisal of Eric V Yeatts

Eric V Yeatts is a junior authorship contributor on recent high-impact multiauthor work linking severe respiratory viral pneumonia to accelerated lung cancer growth in mice and to a modest epidemiologic signal in humans; the principal mechanistic paper is a comprehensive multiomic and mouse model study with translational claims but pending public data deposition and prospective human confirmation Viral pneumonia primes lung cancer preprint

Detailed scientific critique of Eric V Yeatts

Purpose and scope

This review evaluates Eric V Yeatts scientific strength by examining his authored works and measurable publication metrics, and by critically appraising the major mechanistic paper he coauthored on virus priming of lung cancer, noting strengths, weaknesses, reproducibility risks, and open questions. All empirical claims below are cited to the primary sources.

Publication and citation metrics

• OpenAlex and author-level data show a low work count and citation metrics consistent with an early career researcher: works count approximately 1 and h index reported as 1 with cited_by_count about 16 per OpenAlex snapshot; a second related paper appears in Science where Yeatts is a middle author in a large team Science macrophage peroxisome paper
• Aggregate author metrics provided: h index 1 total citations approximately 15 paper count 2 consistent with early stage publishing and team science contributions.

Critical appraisal of the preprint Respiratory viral infections prime accelerated lung cancer growth

The preprint integrates an extremely large retrospective human cohort analysis with deep mechanistic mouse model and single cell multiomic experiments to make a causal claim that severe viral pneumonia can prime the lung microenvironment for accelerated tumor growth Viral pneumonia primes lung cancer preprint

Strengths

• Multimodal evidence chain linking epidemiology to mechanism strengthens plausibility and translational relevance as typically recommended for translational oncology work Convergent multimodal evidence
• Use of modern single cell assays and integration pipelines (Seurat Signac SCENIC pycisTopic) and motif analysis gives mechanistic depth identifying persistent chromatin accessibility changes at cytokine loci which plausibly mediate long term reprogramming scATAC epigenetic remodeling
• Therapeutic rescue experiments in mice (neutrophil depletion CXCR2 inhibition PD L1 blockade and combinations) directly test mechanistic hypotheses and are an important translational step reported by the authors Therapeutic interventions in mice

Limitations and critical caveats

• Human epidemiology is retrospective and observational with large sample size but potential residual confounding particularly by smoking intensity, healthcare contact bias, detection bias (hospitalized patients receive more imaging), and misclassification of exposure severity; authors note these issues and that data availability is pending Epidemiology limitations and confounding
• Translational gap between murine viral strains and human infections: MA10 and PR8 are convenient experimental models but differ immunologically from human SARS CoV 2 and seasonal influenza strains, raising transferability questions for timing, dose, and host genetics effects.
• Data deposition and code availability are pending; reproducibility cannot be fully assessed until raw scRNA seq scATAC seq and cohort code are available as promised by authors, which is an important reproducibility limitation noted in the manuscript metadata Pending data deposition
• Potential for consortium level authorship inflation to obscure individual contribution: Yeatts is a middle author on multi author high complexity papers which is natural in large labs but makes independent assessment of his unique intellectual contribution difficult without contributorship statements.
• Conflict of interest note: University of Virginia filed a provisional patent disclosure on prevention and treatment of viral induced lung cancer which may create potential downstream translational bias; the authors declared this patent disclosure in the manuscript but no direct industry funding conflicts were listed Provisional patent disclosure note

Assessment of Eric V Yeatts role and scientific strength

Interpretation of Yeatts metrics and authorship record suggests early career investigator embedded in collaborative high quality translational immunology oncology research teams. Coauthorship on a Science paper and on the multiomic preprint indicates access to leading methods and contribution to complex projects, but his independent track record (small number of first or senior author publications and low h index) remains limited at present per OpenAlex and provided author metrics.

This pattern is expected for researchers who contribute technical or specialist expertise in multi disciplinary studies; it should not be taken as a negative on scientific capability but rather as an indication that independent leadership evidence is still building.

Where evidence would most strengthen claims and author track record

1. Deposit all raw single cell and cohort code with clear analysis notebooks and parameters to allow replication of scRNA seq scATAC seq and epidemiologic models.
2. Prospective human cohort studies or well controlled longitudinal imaging registries to address detection bias and confounding in the Epic Cosmos signal.
3. Independent replication of the neutrophil SiglecF hi phenotype and CXCR2/PD L1 rescue in different mouse strains and with human organoid or ex vivo human lung tissue to bridge species gap.
4. Clear author contributorship statements to clarify Yeatts specific responsibilities across experiments which strengthens attribution and assessment of expertise.

Conclusions and confidence

Eric V Yeatts appears to be an emerging experimentalist engaged in rigorous, high quality, team based translational research linking respiratory infection to cancer biology; current evidence from his coauthored work is scientifically substantive and methodologically modern but several critical reproducibility and translational gaps remain that the authors themselves acknowledge Authors acknowledge limitations